Skip to content
Homepage
Author:
TELA Bio, Inc.
Posted Date:
May 27, 2026
TELA Bio Reports First Quarter 2026 Financial Results
TELA Bio, Inc.
May 27, 2026
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TELA Bio, Inc.
May 26, 2026
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
TELA Bio, Inc.
May 25, 2026
TELA Bio to Announce First Quarter 2026 Financial Results
TELA Bio, Inc.
May 24, 2026
TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results
TELA Bio, Inc.
May 21, 2026
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
TELA Bio, Inc.
April 30, 2026
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TELA Bio, Inc.
February 20, 2026
